Global Triple Negative Breast Cancer Market size was estimated at USD 689.21 million in 2023. During the forecast period between 2024 and 2030, the Global Triple Negative Breast Cancer Market size is projected to grow at a CAGR of 6.26% reaching a value of USD 933.98 million by 2030. Prominent drivers of the market are the increasing incidences of breast cancer among women under 40, rising frequency of disease recurrences, and the growing need for suitable medical care at private healthcare facilities.